Lansoprazole Tablets Special Drug Use Surveillance Gastroesophageal Reflux Disease With Dyspepsia Symptoms
Status:
Completed
Trial end date:
2010-12-01
Target enrollment:
Participant gender:
Summary
To evaluate the efficacy of 4-week lansoprazole (Takepron) therapy for subjective symptomatic
improvement in gastroesophageal reflux disease patients with dyspepsia symptoms